US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 5.595
  • +0.055+0.99%
Trading Jul 23 13:30 ET
346.08MMarket Cap-4144P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
32.53%24.35M
10.15%75.65M
16.77%22.81M
6.87%18.07M
6.52%16.39M
9.09%18.37M
21.24%68.68M
4.14%19.53M
18.58%16.91M
21.62%15.39M
Selling and administrative expenses
-19.63%5.23M
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
10.04%20.83M
9.41%5.7M
-3.97%4.72M
21.40%5.38M
-General and administrative expense
-19.63%5.23M
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
10.04%20.83M
9.41%5.7M
-3.97%4.72M
21.40%5.38M
Research and development costs
61.18%19.11M
14.63%54.85M
29.96%17.98M
9.43%13.34M
16.58%11.67M
0.36%11.86M
26.85%47.85M
2.11%13.84M
30.44%12.19M
21.74%10.01M
Operating profit
-32.53%-24.35M
-10.15%-75.65M
-16.77%-22.81M
-6.87%-18.07M
-6.52%-16.39M
-9.09%-18.37M
-21.24%-68.68M
-4.14%-19.53M
-18.58%-16.91M
-21.62%-15.39M
Net non-operating interest income expense
5.01%1.05M
133.01%4.5M
53.37%1.25M
92.13%1.42M
161.37%839K
1,565.00%999K
816.11%1.93M
1,795.35%815K
1,468.09%737K
453.45%321K
Non-operating interest income
78.90%2.37M
257.04%7.84M
325.53%4.58M
92.13%1.42M
161.37%839K
2,111.67%1.33M
940.28%2.2M
2,404.65%1.08M
1,468.09%737K
453.45%321K
Non-operating interest expense
303.96%1.33M
1,172.14%3.33M
----
----
----
--328K
--262K
----
----
----
Other net income (expense)
-50.00%-51K
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
-68.78%-319K
535.00%174K
-203.08%-197K
-435.09%-191K
Other non- operating income (expenses)
-50.00%-51K
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
-68.78%-319K
535.00%174K
-203.08%-197K
-435.09%-191K
Income before tax
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
Income tax
Net income
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
Net income continuous Operations
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
Minority interest income
Net income attributable to the parent company
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
Basic earnings per share
5.00%-0.38
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
0.00%-1.78
-147.06%-0.42
36.67%-0.38
28.30%-0.38
Diluted earnings per share
5.00%-0.38
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
0.00%-1.78
-147.06%-0.42
36.67%-0.38
28.30%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 32.53%24.35M10.15%75.65M16.77%22.81M6.87%18.07M6.52%16.39M9.09%18.37M21.24%68.68M4.14%19.53M18.58%16.91M21.62%15.39M
Selling and administrative expenses -19.63%5.23M-0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M10.04%20.83M9.41%5.7M-3.97%4.72M21.40%5.38M
-General and administrative expense -19.63%5.23M-0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M10.04%20.83M9.41%5.7M-3.97%4.72M21.40%5.38M
Research and development costs 61.18%19.11M14.63%54.85M29.96%17.98M9.43%13.34M16.58%11.67M0.36%11.86M26.85%47.85M2.11%13.84M30.44%12.19M21.74%10.01M
Operating profit -32.53%-24.35M-10.15%-75.65M-16.77%-22.81M-6.87%-18.07M-6.52%-16.39M-9.09%-18.37M-21.24%-68.68M-4.14%-19.53M-18.58%-16.91M-21.62%-15.39M
Net non-operating interest income expense 5.01%1.05M133.01%4.5M53.37%1.25M92.13%1.42M161.37%839K1,565.00%999K816.11%1.93M1,795.35%815K1,468.09%737K453.45%321K
Non-operating interest income 78.90%2.37M257.04%7.84M325.53%4.58M92.13%1.42M161.37%839K2,111.67%1.33M940.28%2.2M2,404.65%1.08M1,468.09%737K453.45%321K
Non-operating interest expense 303.96%1.33M1,172.14%3.33M--------------328K--262K------------
Other net income (expense) -50.00%-51K91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K-68.78%-319K535.00%174K-203.08%-197K-435.09%-191K
Other non- operating income (expenses) -50.00%-51K91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K-68.78%-319K535.00%174K-203.08%-197K-435.09%-191K
Income before tax -34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M
Income tax
Net income -34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M
Net income continuous Operations -34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M
Minority interest income
Net income attributable to the parent company -34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M
Basic earnings per share 5.00%-0.3823.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.40.00%-1.78-147.06%-0.4236.67%-0.3828.30%-0.38
Diluted earnings per share 5.00%-0.3823.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.40.00%-1.78-147.06%-0.4236.67%-0.3828.30%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg